Feasibility and Colorectal Benefits of Pulses Supplementation
Feasibility of Pulses Supplementation in Healthy Adults: A Feeding Study
Who can join
Ages 30 to 80 · All sexes · Healthy volunteers welcome
Full eligibility criteria
Inclusions: 1. 30-80 years-old 2. Overweight or obesity (body mass index ≥ 25 kg/m2) 3. Planned for a standard of care colonoscopy for colon cancer screening Exclusions: 1. Intolerance to a bean or high bean consumer based on a screening survey 2. Pregnancy or actively planning to get pregnant 3. Any active gastrointestinal disease resulting in disturbed gut function or malabsorption (e.g., chronic diarrhea or inflammatory bowel disease) 4. Current or history of any malignancy in the past 10 years. 5. Chronic use of opioids, anti-inflammatory drugs, antibiotics, prebiotics, or probiotics within 1 month of study endpoints 6. History of a significant systemic condition (e.g., heart disease, chronic kidney disease, liver dysfunction or immune suppression), or abnormal laboratory markers (e.g., abnormal liver enzymes, creatinine, clotting factors, or low platelets count). The severity of the intolerance to fiber/ the medical conditions/lab markers and eligibility will be defined after the careful interview of the patient/review of the medical records by Dr. Hussan)
About the study
Beans are a forgotten staple food that shows promise in improving health. The goal of this study is to look at how bean supplementation affects metabolic and bowel health. In the long-term, the investigators believe this research will lead to a better understanding of the impact of beans on bowel health. The investigators also hope that this research study will help us understand ways to improve human diet and prevent colon cancer in the future.
What is being tested
- Dry beans (dietary supplement)
- Usual diet (dietary supplement)
Sponsor: University of California, Davis · Participants: 25 · Started: Oct 27, 2023
Contact the study team
- Hisham Hussan, MD · Phone: (916) 734-8246
Official record on ClinicalTrials.gov — NCT06032104
Locations in the U.S.
| California | University of California Davis, Sacramento |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.